[Cholecystokinin (CCK). Physiology and clinical use].
D000596:Amino Acids / Q000032:analysis; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001646:Bile / Q000378:metabolism; D001659:Biliary Tract / Q000187:drug effects; D002415:Cats; D002765:Cholecystography; D002766:Cholecystokinin / Q000032:analysis / Q000037:antagonists & inhibitors / Q000302:isolation & purification / Q000494:pharmacology* / Q000627:therapeutic use; D010856:Columbidae; D003864:Depression, Chemical; D004285:Dogs; D005705:Gallbladder Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D010179:Pancreas / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D010455:Peptides / Q000032:analysis / Q000494:pharmacology; D012633:Secretin / Q000494:pharmacology*; D013268:Stimulation, Chemical
D000596:Amino Acids; D006584:Hexamethonium Compounds; D010455:Peptides; D012633:Secretin; D009020:Morphine; D001285:Atropine; D002766:Cholecystokinin
Cholecystokinin (CCK). Physiologie und klinische Anwendung.